Welcome to Emergent BioSolutions Inc. fourth quarter 2024 earnings conference call. At this time, all participants are in a ...

Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, and Rocketvax Ltd, one of Switzerland’s next ...

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility to Syngene International, a leading ...

Q4 2024 Earnings Call Transcript March 3, 2025 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.05, ...

The “lack of transparency” surrounding the Davis administration’s agreement with SpaceX to allow Falcon 9 booster landings in ...

Turning to Slide 2. During today's call, Emergent may make projections and other forward-looking statements related to their business, future events, their prospects, or future performance.

President Ursula von der Leyen and President António Costa are at the EU-South Africa Summit in Cape Town to strengthen Europe's strategic ...

March 6 (SeeNews) - Romania's Banca Comerciala Romana (BCR) Group, part of Austria's Erste banking group [ BSE:EBS ], said ...